Blockchain Registration Transaction Record

Creative Biolabs Unveils Integrated Immunology and Microfluidic Solutions

Creative Biolabs launches integrated immunology assays and microfluidic solutions for biotherapeutics, including anticomplementary activity and macrophage polarization services.

As biologic modalities grow more diverse, traditional static assays and generic immunology tools often fail to capture the nuanced immune interactions that determine a candidate’s fate. Complement activation, for instance, can trigger unexpected safety signals or reduce efficacy, while macrophage polarization states can shift therapeutic outcomes in ways that simple screens miss. By offering customizable anticomplementary activity assessment, macrophage polarization analysis, and microfluidic systems that better mimic dynamic physiological conditions, Creative Biolabs is equipping researchers to generate more predictive preclinical data. This matters because better early-stage models can reduce late-stage failures, accelerate timelines, and lower costs—ultimately bringing safer, more effective biotherapeutics to patients faster. The integration of these services also reflects a broader industry shift toward holistic, context-dependent immune profiling, where no single assay tells the whole story.